Obesity lowers hyperglycemic threshold for impaired in vivo endothelial nitric oxide function

H. G. Bohlen, Geoffrey P. Nase

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Obesity is a risk for type II diabetes mellitus and increased vascular resistance. Disturbances of nitric oxide (NO) physiology occur in both obese animals and humans, In obese Zucker rats, we determined whether a protein kinase C-ΒII (PKC-ΒII) mechanism may lower the resting NO concentration ([NO]) and predispose endothelial NO abnormalities at lower glucose concentrations than occur in lean rats. NO was measured with microelectrodes touching in vivo intestinal arterioles. At rest, the [NO] in obese Zucker rats was 60 nm less than normal or about a 15% decline. After local blockade of PKC-ΒII with LY-333531, the [NO] increased ∼90 nm in obese rats but did not change in lean rats. In lean rats, administration of 300 mg/dl D-glucose for 45 min depressed endothelium-dependent dilation; only 200 mg/dl was required in obese animals. These various observations indicate that resting [NO] is depressed in obese rats by a PKC-ΒII mechanism and the hyperglycemic threshold for endothelial NO suppression is reduced to 200 mg/dl D-glucose.

Original languageEnglish (US)
Pages (from-to)H391-H397
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume283
Issue number1 52-1
StatePublished - Jul 10 2002

Fingerprint

Nitric Oxide
Obesity
Protein Kinase C
Zucker Rats
Glucose
ruboxistaurin
Arterioles
Microelectrodes
Vascular Resistance
Type 2 Diabetes Mellitus
Endothelium
Dilatation

Keywords

  • Diabetes
  • Hyperglycemia
  • LY-333531

ASJC Scopus subject areas

  • Physiology

Cite this

Obesity lowers hyperglycemic threshold for impaired in vivo endothelial nitric oxide function. / Bohlen, H. G.; Nase, Geoffrey P.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 283, No. 1 52-1, 10.07.2002, p. H391-H397.

Research output: Contribution to journalArticle

@article{f48c89ef947941bf8a3ffb06da602390,
title = "Obesity lowers hyperglycemic threshold for impaired in vivo endothelial nitric oxide function",
abstract = "Obesity is a risk for type II diabetes mellitus and increased vascular resistance. Disturbances of nitric oxide (NO) physiology occur in both obese animals and humans, In obese Zucker rats, we determined whether a protein kinase C-ΒII (PKC-ΒII) mechanism may lower the resting NO concentration ([NO]) and predispose endothelial NO abnormalities at lower glucose concentrations than occur in lean rats. NO was measured with microelectrodes touching in vivo intestinal arterioles. At rest, the [NO] in obese Zucker rats was 60 nm less than normal or about a 15{\%} decline. After local blockade of PKC-ΒII with LY-333531, the [NO] increased ∼90 nm in obese rats but did not change in lean rats. In lean rats, administration of 300 mg/dl D-glucose for 45 min depressed endothelium-dependent dilation; only 200 mg/dl was required in obese animals. These various observations indicate that resting [NO] is depressed in obese rats by a PKC-ΒII mechanism and the hyperglycemic threshold for endothelial NO suppression is reduced to 200 mg/dl D-glucose.",
keywords = "Diabetes, Hyperglycemia, LY-333531",
author = "Bohlen, {H. G.} and Nase, {Geoffrey P.}",
year = "2002",
month = "7",
day = "10",
language = "English (US)",
volume = "283",
pages = "H391--H397",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "1 52-1",

}

TY - JOUR

T1 - Obesity lowers hyperglycemic threshold for impaired in vivo endothelial nitric oxide function

AU - Bohlen, H. G.

AU - Nase, Geoffrey P.

PY - 2002/7/10

Y1 - 2002/7/10

N2 - Obesity is a risk for type II diabetes mellitus and increased vascular resistance. Disturbances of nitric oxide (NO) physiology occur in both obese animals and humans, In obese Zucker rats, we determined whether a protein kinase C-ΒII (PKC-ΒII) mechanism may lower the resting NO concentration ([NO]) and predispose endothelial NO abnormalities at lower glucose concentrations than occur in lean rats. NO was measured with microelectrodes touching in vivo intestinal arterioles. At rest, the [NO] in obese Zucker rats was 60 nm less than normal or about a 15% decline. After local blockade of PKC-ΒII with LY-333531, the [NO] increased ∼90 nm in obese rats but did not change in lean rats. In lean rats, administration of 300 mg/dl D-glucose for 45 min depressed endothelium-dependent dilation; only 200 mg/dl was required in obese animals. These various observations indicate that resting [NO] is depressed in obese rats by a PKC-ΒII mechanism and the hyperglycemic threshold for endothelial NO suppression is reduced to 200 mg/dl D-glucose.

AB - Obesity is a risk for type II diabetes mellitus and increased vascular resistance. Disturbances of nitric oxide (NO) physiology occur in both obese animals and humans, In obese Zucker rats, we determined whether a protein kinase C-ΒII (PKC-ΒII) mechanism may lower the resting NO concentration ([NO]) and predispose endothelial NO abnormalities at lower glucose concentrations than occur in lean rats. NO was measured with microelectrodes touching in vivo intestinal arterioles. At rest, the [NO] in obese Zucker rats was 60 nm less than normal or about a 15% decline. After local blockade of PKC-ΒII with LY-333531, the [NO] increased ∼90 nm in obese rats but did not change in lean rats. In lean rats, administration of 300 mg/dl D-glucose for 45 min depressed endothelium-dependent dilation; only 200 mg/dl was required in obese animals. These various observations indicate that resting [NO] is depressed in obese rats by a PKC-ΒII mechanism and the hyperglycemic threshold for endothelial NO suppression is reduced to 200 mg/dl D-glucose.

KW - Diabetes

KW - Hyperglycemia

KW - LY-333531

UR - http://www.scopus.com/inward/record.url?scp=0036302686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036302686&partnerID=8YFLogxK

M3 - Article

C2 - 12063313

AN - SCOPUS:0036302686

VL - 283

SP - H391-H397

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 1 52-1

ER -